Kusumam Joseph - Publications
Affiliations: | 2010-2014 | Biocryst Pharmaceuticals |
Year | Citation | Score | |||
---|---|---|---|---|---|
2021 | Annamalai B, Parsons N, Nicholson C, Joseph K, Coughlin B, Yang X, Jones BW, Tomlinson S, Rohrer B. Natural immunoglobulin M-based delivery of a complement alternative pathway inhibitor in mouse models of retinal degeneration. Experimental Eye Research. 108583. PMID 33878326 DOI: 10.1016/j.exer.2021.108583 | 0.499 | |||
2016 | Coughlin B, Schnabolk G, Joseph K, Raikwar H, Kunchithapautham K, Johnson K, Moore K, Wang Y, Rohrer B. Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells. Scientific Reports. 6: 23794. PMID 27029558 DOI: 10.1038/Srep23794 | 0.461 | |||
2015 | Schnabolk G, Coughlin B, Joseph K, Kunchithapautham K, Bandyopadhyay M, O'Quinn EC, Nowling T, Rohrer B. Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization. Investigative Ophthalmology & Visual Science. 56: 1850-63. PMID 25593023 DOI: 10.1167/Iovs.14-15910 | 0.506 | |||
2013 | Joseph K, Kulik L, Coughlin B, Kunchithapautham K, Bandyopadhyay M, Thiel S, Thielens NM, Holers VM, Rohrer B. Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner. The Journal of Biological Chemistry. 288: 12753-65. PMID 23493397 DOI: 10.1074/Jbc.M112.421891 | 0.511 | |||
Show low-probability matches. |